SCHEMBL3605375

SCHEMBL3605375

COCC(C)Oc1cc(Br)cc(C(=O)O)c1

nearest known ligand 0.49

Predicted protein targets (top 5)

geneUniProtsupporting neighboursconfidence
GCK P35557 18/20 0.49
RARA P10276 1/20 0.46
RARB P10826 1/20 0.46
RARG P13631 1/20 0.44
PLA2G2A P14555 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1107734 0.89 GCK (0.57) GCKRARARARBRARGPLA2G2A
SCHEMBL1107709 0.85 GCK (0.55) GCKRARARARBRARG
SCHEMBL1107706 0.85 GCK (0.63) GCKRARARARBRARG
SCHEMBL2172360 0.85 GCK (0.37) GCKRARARARBRARGPLA2G2A
SCHEMBL3595570 0.85 GCK (0.37) GCKRARARARBRARGPLA2G2A
SCHEMBL3605126 0.84 PLA2G2A (0.40) GCKRARARARBPLA2G2A
SCHEMBL12408474 0.84 GCK (0.50) GCKRARARARBRARG
SCHEMBL320803 0.84 GCK (0.50) GCKRARARARBRARG
SCHEMBL2654383 0.84 GCK (0.50) GCKRARARARBRARG
SCHEMBL2178326 0.82 GCK (0.52) GCKRARARARBRARG

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7700640-B2 Process for making phenoxy benzamide compounds ASTRAZENECA AB (SE) 2010-04-20 US disclosed
US-20080200694-A1 Process for Making Phenoxy Benzamide Compounds ASTRAZENECA AB (SE) 2008-08-21 US disclosed
EP-1802570-A1 PROCESS FOR MAKING PHENOXY BENZAMIDE COMPOUNDS AstraZeneca AB (SE) 2007-07-04 EP disclosed
WO-2006040527-A1 PROCESS FOR MAKING PHENOXY BENZAMIDE COMPOUNDS ASTRAZENECA AB (SE) 2006-04-20 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080200694-A1 Process for Making Phenoxy Benzamide Compounds PAH, MAOB, TYR GCK 1415/4885RARA 1811/4885RARB 1685/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.